maridebart cafraglutide vs tirzepatide Another new drug is being tested for the treatment of obesity and type 2 diabetes—and looks very promising! by Amgen similarly targets GLP-1R and GIPR. Just please don’t make AMG 133 (maridebart cafraglutide) weight

Doctors published a three-patient case series in

Semaglutide works by mimicking the body's natural insulin response, stimulating insulin secretion, and reducing glucagon secretion

Strengths Acts via multiple pathways (GLP-1, AMPK, microbiome) Has existing human data showing reductions in fasting glucose, HbA1c, lipids Support receptor expression and islet health Limitations Low absorption and bioavailability Gastrointestinal discomfort is common (diarrhea, cramping)

Shop doctor-formulated transdermal patches for weight loss, NAD+ energy, GLP-1 support, and menopause relief

Clinical oversight included

Heres a clear, professional breakdown: What They Are Ozempic (semaglutide) A once-weekly GLP-1 receptor agonist originally developed for type 2 diabetes